Skip to main content
SpringerLink
Log in

Endogenous sex hormones and their associations with cardiovascular risk factors in post-menopausal women

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aims: Our aim was to understand the relationship between endogenous sex hormones and cardiovascular disease (CVD) risk factors in post-menopausal women. Materials and methods: Eighty-three post-menopausal women from a previous prospectively designed study were included. We analyzed endogenous sex hormones and biochemical parameters. Results: Levels of estradiol and free testosterone were higher in patients with metabolic syndrome. Estradiol correlated positively with interleukin-6 (IL-6), weight, body mass index (BMI), insulin, homocysteine, and homeostasis model assessment of insulin resistance (HOMA-IR). Free testosterone correlated positively with weight, waist circumference (WC), BMI, insulin, HOMA-IR and negatively with HDL and SHBG. DHEAS correlated only with HDL. FSH correlated negatively with age, weight, WC, hip circumference, BMI, systolic blood pressure, diastolic blood pressure, duration of menopause, fasting glucose, HDL, C-reactive protein, and insulin. LH correlated negatively with IL-6, age, WC, duration of menopause and SHBG. Conclusions: We identified endogenous estradiol and free testosterone as the strongest links to CVD risk. They can be used as biomarkers for CVD risk estimation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987, 114: 413–9.

    Article  PubMed  Google Scholar 

  2. Carr MC. The emergence of the metabolic syndrome with the menopause. J Clin Endocrinol Metab 2003, 88: 2404–11.

    Article  PubMed  Google Scholar 

  3. Rexrode KM, Manson JE, Lee I, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108: 1688–93.

    Article  PubMed  Google Scholar 

  4. Ridker PM, Hennekens CH, Bruing JF, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342: 836–43.

    Article  PubMed  Google Scholar 

  5. Sites CK, Toth MJ, Cushman M, et al. Menopause related differences in inflammation markers and their relationship to body fat distribution and insulin stimulated glucose disposal. Fertil Steril 2002, 77: 128–35.

    Article  PubMed  Google Scholar 

  6. Pradhan AD, Mason JE, Rossouw JE, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease. Prospective analysis form the Women’s Health Initiative observational study. JAMA 2002, 288: 980–7.

    Article  PubMed  Google Scholar 

  7. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Report Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults treatment Panel III). JAMA 2001, 285: 2486–97.

    Article  Google Scholar 

  8. Kramer PR, Kramer SF, Guan G. 17 beta-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum 2004, 50: 1967–75.

    Article  PubMed  Google Scholar 

  9. Davison S, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003, 88: 2470–8.

    Article  PubMed  Google Scholar 

  10. Wassel CL, Barrett-Connor E, Laughlin GA. Association of circulating C-reactive protein and interleukin-6 with longetivity into the 80s and 90s: The Rancho Bernardo Study. J Clin Endocrinol Metab 2010, 95: 4748–55.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Lacut K, Oger E, Le Gal G, et al. SARAH Investigators. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein. Thromb Haemost 2003, 90: 124–31.

    PubMed  Google Scholar 

  12. Cooper BC, Burger NZ, Toth MJ, Cushman M, Sites CK. Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol 2007, 196: 1–7.

    Article  Google Scholar 

  13. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83: 847–50.

    PubMed  Google Scholar 

  14. Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal I. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res 2008, 49: 1015–23.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Blum CA, Müller B, Huber P, et al. Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women. J Clin Endocrinol Metab 2005, 90: 3230–5.

    Article  PubMed  Google Scholar 

  16. Störk S, Bots ML, Grobbee DE, van der Schouw YT. Endogenous sex hormones and C reactive protein in healthy postmenopausal women. J Intern Med 2008, 264: 245–53.

    Article  PubMed  Google Scholar 

  17. Maggio M, Ceda GP, Lauretani F, et al. SHBG, Sex hormones, and inflammatory markers in older women. J Clin Endocrinol Metab 2011, 96: 1053–9.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Karim R, Stanczyk FZ, Hodis HN, et al. Associations between markers of inflammation and physiological and pharmacological levels of circulating sex hormones in postmenopausal women. Menopause 2010, 17: 785–90.

    PubMed Central  PubMed  Google Scholar 

  19. Yesilova Z, Ozata M, Kocar IH, et al. The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2000, 85: 66–70.

    Article  PubMed  Google Scholar 

  20. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002, 87: 3632–9.

    Article  PubMed  Google Scholar 

  21. Kocoska-Maras L, Hirschberg AL, Byström B, Schoultz BV, Rådestad AF. Testosterone addition to estrogen therapy — effects on inflammatory markers for cardiovascular disease. Gynecol Endocrinol 2009, 25: 823–7.

    Article  PubMed  Google Scholar 

  22. Philips GB, Pinkernell BH, Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol 1997, 17: 695–701.

    Article  Google Scholar 

  23. Golden SH, Maguire A, Ding J, et al. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol 2002, 155: 437–45.

    Article  PubMed  Google Scholar 

  24. Bernini GP, Sgro’ M, Moretti A, et al. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999, 84: 2008–12.

    Article  PubMed  Google Scholar 

  25. Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol 2006, 16: 105–12.

    Article  PubMed  Google Scholar 

  26. Crandall C, Palla S, Reboussin B, et al. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. J Womens Health (Larchmt) 2006, 15: 14–23.

    Article  Google Scholar 

  27. Maturana MA, Breda V, Lhullier F, Spitzer PM. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism 2008, 57: 961–5.

    Article  PubMed  Google Scholar 

  28. Hsu SC, Liu CM, Long CY, Yang CH, Lee JN, Tsai EM. Effect of oral conjugated equine estrogen combined with medroxyprogesterone acetate on plasma homocysteine levels in postmenopausal women. Fertil Steril 2005, 84: 1037–9.

    Article  PubMed  Google Scholar 

  29. Christodoulakos GE, Lambrinoudaki IV, Rizos DA, Alexandrou A, Kountouris AV, Creatsas GC. Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women. Hormones (Athens) 2006, 5: 35–41.

    Article  Google Scholar 

  30. Bedranek-Tupikowska G, Tupikowski K, Bohdanowicz-Pawlak A, et al. Evaluation of the influence of sex hormones on homocysteine concentration in pre- and postmenopausal women. Pol Merkur Lekarski 2005, 18: 189–91.

    Google Scholar 

  31. Weinberg ME, Manson JE, Buring JE, et al. Low sex hormone binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism 2006, 55: 1473–80.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Korhonen S, Hippelainen M, Vanhala M, Heinonen S, Niskanen L. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil Steril 2003, 79: 1327–34.

    Article  PubMed  Google Scholar 

  33. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and metaanalysis. JAMA 2006, 295: 1288–99.

    Article  PubMed  Google Scholar 

  34. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 2004, 160: 540–8.

    Article  PubMed  Google Scholar 

  35. Larsson H, Ahren B. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Diabetes Care 1996, 19: 1399–403.

    Article  PubMed  Google Scholar 

  36. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001, 24: 925–32.

    Article  PubMed  Google Scholar 

  37. Sowers MF, Zheng H, Tomey K, et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab 2007, 92: 895–901.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Istanbul Bilim University, Kisikli cad. No. 106, Altunizade, 34692, Istanbul, Turkey

    N. Güdücü MD

  2. Department of Biochemistry, Istanbul Bilim University, Istanbul, Turkey

    U. Görmüş

  3. Department of Cardiovascular Surgery, Marmara University, Istanbul, Turkey

    S. S. Kutay

  4. Department of Obstetrics and Gynecology, Marmara University, Istanbul, Turkey

    Z. N. Kavak

  5. Department of Family Medicine, Istanbul Bilim University, Istanbul, Turkey

    B. Telatar

Authors
  1. N. Güdücü MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Görmüş
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. S. Kutay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. N. Kavak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Telatar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Güdücü MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Güdücü, N., Görmüş, U., Kutay, S.S. et al. Endogenous sex hormones and their associations with cardiovascular risk factors in post-menopausal women. J Endocrinol Invest 36, 588–592 (2013). https://doi.org/10.3275/8881

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/8881

Key-words

Search

Navigation